Tolga Tanguler's most recent trade in Alnylam Pharmaceuticals Inc was a trade of 767 Common Stock done at an average price of $323.8 . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 323.84 per share. | 04 Mar 2026 | 767 | 34,777 (0%) | 0% | 323.8 | 248,385 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 323.01 per share. | 04 Mar 2026 | 350 | 35,544 (0%) | 0% | 323.0 | 113,054 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 321.82 per share. | 04 Mar 2026 | 289 | 35,894 (0%) | 0% | 321.8 | 93,006 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 324.88 per share. | 04 Mar 2026 | 272 | 34,505 (0%) | 0% | 324.9 | 88,367 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 320.81 per share. | 04 Mar 2026 | 215 | 36,183 (0%) | 0% | 320.8 | 68,974 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 325.67 per share. | 04 Mar 2026 | 208 | 34,297 (0%) | 0% | 325.7 | 67,739 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 319.03 per share. | 04 Mar 2026 | 106 | 36,500 (0%) | 0% | 319.0 | 33,817 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 320.01 per share. | 04 Mar 2026 | 102 | 36,398 (0%) | 0% | 320.0 | 32,641 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 10,480 | 10,480 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 4,769 | 38,204 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 326.81 per share. | 02 Mar 2026 | 392 | 37,417 (0%) | 0% | 326.8 | 128,110 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 327.67 per share. | 02 Mar 2026 | 329 | 37,088 (0%) | 0% | 327.7 | 107,803 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 325.63 per share. | 02 Mar 2026 | 258 | 37,809 (0%) | 0% | 325.6 | 84,013 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 329.71 per share. | 02 Mar 2026 | 170 | 36,818 (0%) | 0% | 329.7 | 56,051 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 328.71 per share. | 02 Mar 2026 | 100 | 36,988 (0%) | 0% | 328.7 | 32,871 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 331.93 per share. | 02 Mar 2026 | 94 | 36,643 (0%) | 0% | 331.9 | 31,201 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 324.66 per share. | 02 Mar 2026 | 90 | 38,067 (0%) | 0% | 324.7 | 29,219 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 330.85 per share. | 02 Mar 2026 | 81 | 36,737 (0%) | 0% | 330.9 | 26,799 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 323.62 per share. | 02 Mar 2026 | 47 | 38,157 (0%) | 0% | 323.6 | 15,210 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 332.65 per share. | 02 Mar 2026 | 37 | 36,606 (0%) | 0% | 332.6 | 12,308 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 1,666 | 0 | - | - | Restricted Stock Units | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 1,666 | 33,435 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 4,000 | 33,728 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 310.08 per share. | 12 Feb 2026 | 1,959 | 31,769 (0%) | 0% | 310.1 | 607,448 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2026 | 3,800 | 31,238 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 365.56 per share. | 11 Jan 2026 | 220 | 30,020 (0%) | 0% | 365.6 | 80,423 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 364.83 per share. | 11 Jan 2026 | 199 | 30,240 (0%) | 0% | 364.8 | 72,601 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 360.22 per share. | 11 Jan 2026 | 155 | 30,657 (0%) | 0% | 360.2 | 55,834 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 358.18 per share. | 11 Jan 2026 | 123 | 30,897 (0%) | 0% | 358.2 | 44,056 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 361.45 per share. | 11 Jan 2026 | 98 | 30,559 (0%) | 0% | 361.4 | 35,422 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 357.17 per share. | 11 Jan 2026 | 96 | 31,020 (0%) | 0% | 357.2 | 34,288 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 368.62 per share. | 11 Jan 2026 | 92 | 29,837 (0%) | 0% | 368.6 | 33,913 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 359.14 per share. | 11 Jan 2026 | 85 | 30,812 (0%) | 0% | 359.1 | 30,527 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 362.38 per share. | 11 Jan 2026 | 73 | 30,486 (0%) | 0% | 362.4 | 26,454 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 366.42 per share. | 11 Jan 2026 | 50 | 29,970 (0%) | 0% | 366.4 | 18,321 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 363.55 per share. | 11 Jan 2026 | 47 | 30,439 (0%) | 0% | 363.6 | 17,087 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 355.17 per share. | 11 Jan 2026 | 42 | 31,157 (0%) | 0% | 355.2 | 14,917 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 356.10 per share. | 11 Jan 2026 | 41 | 31,116 (0%) | 0% | 356.1 | 14,600 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 367.39 per share. | 11 Jan 2026 | 41 | 29,929 (0%) | 0% | 367.4 | 15,063 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 369.48 per share. | 11 Jan 2026 | 40 | 29,797 (0%) | 0% | 369.5 | 14,779 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 353.95 per share. | 11 Jan 2026 | 39 | 31,199 (0%) | 0% | 353.9 | 13,804 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 370.89 per share. | 11 Jan 2026 | 19 | 29,778 (0%) | 0% | 370.9 | 7,047 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 375.63 per share. | 11 Jan 2026 | 19 | 29,743 (0%) | 0% | 375.6 | 7,137 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 377.80 per share. | 11 Jan 2026 | 15 | 29,728 (0%) | 0% | 377.8 | 5,667 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 374.43 per share. | 11 Jan 2026 | 14 | 29,762 (0%) | 0% | 374.4 | 5,242 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 372.50 per share. | 11 Jan 2026 | 2 | 29,776 (0%) | 0% | 372.5 | 745 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 2,851 | 28,843 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 452.69 per share. | 01 Oct 2025 | 319 | 27,818 (0%) | 0% | 452.7 | 144,408 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 450.81 per share. | 01 Oct 2025 | 260 | 28,296 (0%) | 0% | 450.8 | 117,211 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 451.86 per share. | 01 Oct 2025 | 159 | 28,137 (0%) | 0% | 451.9 | 71,846 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 453.77 per share. | 01 Oct 2025 | 157 | 27,661 (0%) | 0% | 453.8 | 71,242 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 449.79 per share. | 01 Oct 2025 | 119 | 28,556 (0%) | 0% | 449.8 | 53,525 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 454.84 per share. | 01 Oct 2025 | 117 | 27,544 (0%) | 0% | 454.8 | 53,216 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 448.77 per share. | 01 Oct 2025 | 86 | 28,675 (0%) | 0% | 448.8 | 38,594 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 457.43 per share. | 01 Oct 2025 | 70 | 27,439 (0%) | 0% | 457.4 | 32,020 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 446.53 per share. | 01 Oct 2025 | 55 | 28,788 (0%) | 0% | 446.5 | 24,559 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 455.83 per share. | 01 Oct 2025 | 35 | 27,509 (0%) | 0% | 455.8 | 15,954 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 447.93 per share. | 01 Oct 2025 | 27 | 28,761 (0%) | 0% | 447.9 | 12,094 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 458.00 per share. | 01 Oct 2025 | 1 | 27,438 (0%) | 0% | 458 | 458 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 448.05 per share. | 29 Aug 2025 | 1,289 | 27,083 (0%) | 0% | 448.0 | 577,536 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 446.98 per share. | 29 Aug 2025 | 899 | 28,372 (0%) | 0% | 447.0 | 401,835 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 449.54 per share. | 29 Aug 2025 | 681 | 26,402 (0%) | 0% | 449.5 | 306,137 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 451.52 per share. | 29 Aug 2025 | 266 | 26,136 (0%) | 0% | 451.5 | 120,104 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 445.53 per share. | 29 Aug 2025 | 195 | 29,271 (0%) | 0% | 445.5 | 86,878 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 452.49 per share. | 29 Aug 2025 | 144 | 25,992 (0%) | 0% | 452.5 | 65,159 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 2,851 | 30,862 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 454.04 per share. | 15 Aug 2025 | 543 | 29,719 (0%) | 0% | 454.0 | 246,544 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 452.96 per share. | 15 Aug 2025 | 329 | 30,262 (0%) | 0% | 453.0 | 149,024 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 454.84 per share. | 15 Aug 2025 | 241 | 29,478 (0%) | 0% | 454.8 | 109,616 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 451.99 per share. | 15 Aug 2025 | 103 | 30,591 (0%) | 0% | 452.0 | 46,555 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 449.92 per share. | 15 Aug 2025 | 90 | 30,733 (0%) | 0% | 449.9 | 40,493 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 450.92 per share. | 15 Aug 2025 | 39 | 30,694 (0%) | 0% | 450.9 | 17,586 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 447.97 per share. | 15 Aug 2025 | 39 | 30,823 (0%) | 0% | 448.0 | 17,471 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 455.83 per share. | 15 Aug 2025 | 12 | 29,466 (0%) | 0% | 455.8 | 5,470 | Common Stock |
| Lexeo Therapeutics Inc | Tolga Tanguler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 14,583 | 14,583 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 14,137 | 28,482 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 7,819 | 7,819 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 243.36 per share. | 03 Mar 2025 | 142 | 28,209 (0%) | 0% | 243.4 | 34,557 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 242.37 per share. | 03 Mar 2025 | 131 | 28,351 (0%) | 0% | 242.4 | 31,750 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 244.41 per share. | 03 Mar 2025 | 96 | 28,113 (0%) | 0% | 244.4 | 23,463 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 245.26 per share. | 03 Mar 2025 | 70 | 28,043 (0%) | 0% | 245.3 | 17,168 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 246.17 per share. | 03 Mar 2025 | 29 | 28,014 (0%) | 0% | 246.2 | 7,139 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 247.33 per share. | 03 Mar 2025 | 3 | 28,011 (0%) | 0% | 247.3 | 742 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,667 | 1,666 | - | - | Restricted Stock Units | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,667 | 14,858 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 242.44 per share. | 27 Feb 2025 | 192 | 14,461 (0%) | 0% | 242.4 | 46,548 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 241.51 per share. | 27 Feb 2025 | 82 | 14,653 (0%) | 0% | 241.5 | 19,804 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 243.23 per share. | 27 Feb 2025 | 78 | 14,383 (0%) | 0% | 243.2 | 18,972 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 240.32 per share. | 27 Feb 2025 | 50 | 14,735 (0%) | 0% | 240.3 | 12,016 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 244.11 per share. | 27 Feb 2025 | 38 | 14,345 (0%) | 0% | 244.1 | 9,276 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 236.50 per share. | 27 Feb 2025 | 28 | 14,830 (0%) | 0% | 236.5 | 6,622 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 239.17 per share. | 27 Feb 2025 | 23 | 14,785 (0%) | 0% | 239.2 | 5,501 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 238.32 per share. | 27 Feb 2025 | 22 | 14,808 (0%) | 0% | 238.3 | 5,243 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 3,000 | 14,660 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 251.42 per share. | 25 Nov 2024 | 826 | 13,275 (0%) | 0% | 251.4 | 207,673 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 250.68 per share. | 25 Nov 2024 | 318 | 14,101 (0%) | 0% | 250.7 | 79,716 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 249.60 per share. | 25 Nov 2024 | 215 | 14,419 (0%) | 0% | 249.6 | 53,664 | Common Stock |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 252.27 per share. | 25 Nov 2024 | 84 | 13,191 (0%) | 0% | 252.3 | 21,191 | Common Stock |
| Alnylam Pharma Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 247.77 per share. | 25 Nov 2024 | 26 | 14,634 (0%) | 0% | 247.8 | 6,442 | Common Stock |
| Lexeo Therapeutics Inc | Tolga Tanguler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2024 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 3,278 | 13,265 (0%) | 0% | 0 | Common Stock |